ESSEX BIO-TECHNOLOGY
Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and devel... opment of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects. A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin.
ESSEX BIO-TECHNOLOGY
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
1990-01-01
Status:
Active
Contact:
(+852) 2587 7838
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro Google Maps PHP Apple Mobile Web App Capable IIS Apple Mobile Web App Status Bar Style IIS 7
Similar Organizations
Pharming Group
Pharming Group is a developer and manufacturer of human therapeutic proteins.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-05-01 | X-ZELL | Essex Bio-Technology investment in Seed Round - X-ZELL | 4 M USD |
| 2018-03-16 | MeiraGTx | Essex Bio-Technology investment in Series B - MeiraGTx | 5 M USD |
More informations about "Essex Bio-Technology"
EssexBio
Essex Bio-Technology Announces 2021 Financial Results Achieves an increase of 58% in Profit-After-Tax to HK$346.0 million and Turnover Growth of 67.4% to HK$1,637.7 million …See details»
Essex Bio-Technology - Crunchbase Investor Profile
Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in …See details»
EssexBio
Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic rb-bFGF (FGF-2), having six commercialized biologics marketed in China since 1998.See details»
Essex Bio-Technology - LinkedIn
Essex Bio-Technology is a bio-pharmaceutical company with its key products marketed in more than 10,000 hospitals since 1998. The company is focused on developing biologics and pharmaceuticals in ...See details»
EssexBio
Aug 15, 2022 About Essex (1061.HK) Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic b-bFGF (FGF-2), having six …See details»
Essex Bio-Technology Company Description - Stock Analysis
Nov 22, 2024 Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells bio-pharmaceutical products in the People’s Republic of …See details»
Essex Bio-Technology Announces Upcoming Presentation at
Essex Bio-Technology Announces Upcoming Presentation at ARVO 2021 Annual Meeting Hong Kong, 30 Apr 2021 Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) …See details»
Essex Bio-Technology | Company Overview & News - Forbes
Essex Bio-Technology develops biopharmaceutical drugs based on recombinant DNA technology for the treatment and healing of surface wounds and eye wounds. The company was founded …See details»
Essex Bio-Technology - Overview, News & Similar companies
Mar 18, 2024 Who is Essex Bio-Technology. Essex Bio-Technology Limited is a bio-pharmaceutical company that develops, manufactures and commercialises genetically …See details»
Essex Bio-technology 2025 Company Profile: Stock
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and …See details»
EssexBio
Essex Bio-Technology (1061.HK) 2024 Annual Results at a glance 2025.03.26 Related news Essex Bio-Technology (1061.HK) 2024 Annual Results at a glance 2025-03-26 Essex Bio …See details»
Essex Bio-Technology Company Profile - Craft
Oct 29, 2024 Essex Bio-Technology (億勝生物科技) is a company that specializes in drug development based on recombinant DNA technology. It operates in two segments: …See details»
Essex Bio-Technology Ltd, 1061:HKG profile - FT.com - Financial …
Mar 11, 2025 Year on year Essex Bio-Technology Ltd grew net income 22.11% from 225.41m to 275.26m primarily through revenue growth (1.32bn to 1.71bn). For while the costs associated …See details»
ESSEX BIO-TECH: Why I bought HK-listco founded by Singaporean …
Jul 20, 2020 A lot of companies have suffered in terms of profitability due to COVID-19, not just Essex Bio-Tech. It is only during these uncertain times when good companies sell at cheap …See details»
Essex Biotechnology Secures Exclusive Global Rights and Interests …
Hong Kong, 13 Oct 2022 Essex Bio-Technology Limited (the “Company”, together with its subsidiaries, the “Group”) wishes to announce that Essex Bio-Investment Limited (“Essex Bio …See details»
Essex Bio-Technology. Information about the issuer. . News and …
Essex Bio-Technology. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Essex Bio-Technology Announces 2022 Interim Financial Results
Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2022. Financial Performance During the …See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 A one-of-a-kind facility in Canada, the Neptune BioInnovation Centre (NBC) will encourage biotechnology advancements in areas such as smart materials, bioplastics, …See details»
EssexBio
Aug 26, 2024 Essex Bio-Technology Included in Forbes Asia's Best Under A Billion 2024 2024.08.26 Download. Hong Kong, 26 Aug 2024 Essex Bio-Technology Ltd (“Essex” or the …See details»
Essex Bio-Technology Reports Stellar 2024 Annual Results Net …
Essex Bio-Technology Reports Stellar 2024 Annual Results Net Profit soars 11.6% to HK$ 307.2 Million, Dividend increases 33.3% Focuses on Strengthening R&D Capabilities and Expanding …See details»